Latest filing published 30 Oct 2019 for Phathom Pharmaceuticals, Inc., €13.6M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +66.6%Entry US$23.62 · Close at T+365 US$39.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jonathan S. Edwards: trading record in brief
Jonathan S. Edwards is a declared insider of Phathom Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 4 filings cover trades dated 29 October 2019.
Purchases make up the whole of the open-market record (2 purchases, €18.0M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 30 October 2019: a transaction of €13.6M, in Phathom Pharmaceuticals, Inc. The clock since the last published purchase (30 October 2019) now reads 2,567 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jonathan S. Edwards
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 991,672 shares@ US$15.2042.5% of flowCommon StockSEC:0001209191-19-054530:0
- 23,558 shares@ US$15.201.0% of flowCommon StockSEC:0001209191-19-054530:1
- 1,028,205 shares@ US$19.0055.1% of flowCommon StockSEC:0001209191-19-054530:2Canonical exit: 27 Jan 2020 (T+90)
- 24,426 shares@ US$19.001.3% of flowCommon StockSEC:0001209191-19-054530:3Canonical exit: 27 Jan 2020 (T+90)
4 of 4 declarations
